Discover open access scientific publications

Search, annotate, share and cite publications

Publications by O. Kuittinen

Early Progression of Mantle Cell Lymphoma Depicts a High-Risk Disease With Poor Response to Subsequent Therapies and a Dismal Outcome

Hematological Oncology

English

Risk of Secondary Hematological Malignancy in Patients With Follicular Lymphoma

Hematological Oncology

English

Related publications

Follicular Lymphoma With Progression to Diffuse Large B-Cell Lymphoma and Concurrent CD5-Negative Mantle Cell Lymphoma-3 Entities in a Lymph Node

English

Improved Outcome for Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL) Who Stop Ibrutinib +/− Rituximab for Reasons Other Than Progression of Disease

Hematological Oncology

English

A Pilot Study to Evaluate 3'-Deoxy-3'-18f-Fluorothymidine PET for Initial and Early Response Imaging in Mantle Cell Lymphoma

Journal of Nuclear Medicine

English

Mantle Cell Lymphoma Superimposed on Multicentric Castleman's Disease

Journal of clinical and experimental hematopathology : JCEH

Medicine

2011

English

B7-H3 Silencing Inhibits Tumor Progression of Mantle Cell Lymphoma and Enhances Chemosensitivity

International Journal of Oncology

Cancer Research

Oncology

2015

English

Short Diagnosis-To-Treatment Interval Is Associated With High Risk and Poor Outcomes in Diffuse Large B-Cell Lymphoma

Hematological Oncology

English

Refining the Mantle Cell Lymphoma Paradigm: Impact of Novel Therapies on Current Practice

Clinical Cancer Research

Cancer Research

Oncology

2015

English

Serum Biomarkers Are Associated With Treatment Response in Relapsed Mantle Cell Lymphoma

Hematological Oncology

English

Diffuse Large B-Cell Lymphoma With Primary Treatment Failure: Ultra-High Risk Features and Benchmarking for Experimental Therapies

American Journal of Hematology

Hematology

2017

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by O. Kuittinen

Early Progression of Mantle Cell Lymphoma Depicts a High-Risk Disease With Poor Response to Subsequent Therapies and a Dismal Outcome

Risk of Secondary Hematological Malignancy in Patients With Follicular Lymphoma

Related publications

Follicular Lymphoma With Progression to Diffuse Large B-Cell Lymphoma and Concurrent CD5-Negative Mantle Cell Lymphoma-3 Entities in a Lymph Node

Improved Outcome for Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL) Who Stop Ibrutinib +/− Rituximab for Reasons Other Than Progression of Disease

A Pilot Study to Evaluate 3'-Deoxy-3'-18f-Fluorothymidine PET for Initial and Early Response Imaging in Mantle Cell Lymphoma

Mantle Cell Lymphoma Superimposed on Multicentric Castleman's Disease

B7-H3 Silencing Inhibits Tumor Progression of Mantle Cell Lymphoma and Enhances Chemosensitivity

Short Diagnosis-To-Treatment Interval Is Associated With High Risk and Poor Outcomes in Diffuse Large B-Cell Lymphoma

Refining the Mantle Cell Lymphoma Paradigm: Impact of Novel Therapies on Current Practice

Serum Biomarkers Are Associated With Treatment Response in Relapsed Mantle Cell Lymphoma

Diffuse Large B-Cell Lymphoma With Primary Treatment Failure: Ultra-High Risk Features and Benchmarking for Experimental Therapies